Qiagen Closes Cellestis Acquisition (LIFE) (QGEN) (SIAL)
Recently, Qiagen ( QGEN ) completed the acquisition of Australia-based Cellestis Limited. Although the deal to acquire Cellestis was announced initially in April 2011, in July, Qiagen increased the offer price by 7% to $4.06 (A$3.80) per share. […]